Form 8-K - Current report:
SEC Accession No. 0001193125-24-194907
Filing Date
2024-08-06
Accepted
2024-08-06 16:16:59
Documents
14
Period of Report
2024-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d859161d8k.htm   iXBRL 8-K 25611
2 EX-99.1 d859161dex991.htm EX-99.1 118761
  Complete submission text file 0001193125-24-194907.txt   276210

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctkb-20240806.xsd EX-101.SCH 2840
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctkb-20240806_lab.xml EX-101.LAB 17234
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctkb-20240806_pre.xml EX-101.PRE 10805
16 EXTRACTED XBRL INSTANCE DOCUMENT d859161d8k_htm.xml XML 3505
Mailing Address 47215 LAKEVIEW BOULEVARD FREMONT CA 94538
Business Address 47215 LAKEVIEW BOULEVARD FREMONT CA 94538 (877) 922-9835
Cytek Biosciences, Inc. (Filer) CIK: 0001831915 (see all company filings)

EIN.: 472547526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40632 | Film No.: 241179515
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)